Negative impactResults
Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginally
Economic Times 57 min ago·23 Oct 2026, 1:32 pm
Dr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America weakness pressured performance, offset partly by growth in India and emerging markets, alongside biosimilar approvals and strategic partnerships.
Affected stocks
Bearish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns DR. Reddy S Laboratories (DRREDDY).
- Category: Results.
- AI reads the tone as negative (potentially bearish) for the stock.
Why it matters
A routine update for DR. Reddy S Laboratories. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.
